Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2002 1
2004 2
2008 1
2009 4
2010 1
2011 1
2012 1
2013 3
2014 3
2015 2
2016 3
2017 1
2018 3
2019 6
2020 6
2021 3
2022 4
2023 2
2024 2
2025 2
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Rosacea management: A comprehensive review.
Sharma A, Kroumpouzos G, Kassir M, Galadari H, Goren A, Grabbe S, Goldust M. Sharma A, et al. J Cosmet Dermatol. 2022 May;21(5):1895-1904. doi: 10.1111/jocd.14816. Epub 2022 Feb 14. J Cosmet Dermatol. 2022. PMID: 35104917 Review.
Rosacea is a chronic cutaneous disorder affecting primarily the face, characterized by erythema, transient or persistent, telangiectasia, and inflammatory lesions including papulo-pustules and swelling. ...Topical medications such as azelaic acid, metronidazo …
Rosacea is a chronic cutaneous disorder affecting primarily the face, characterized by erythema, transient or persisten …
Rosacea Management.
Abokwidir M, Feldman SR. Abokwidir M, et al. Skin Appendage Disord. 2016 Sep;2(1-2):26-34. doi: 10.1159/000446215. Epub 2016 May 18. Skin Appendage Disord. 2016. PMID: 27843919 Free PMC article. Review.
Nonselective beta-blockers and alpha(2)-adrenergic agonists decrease erythema and flushing. The topical alpha-adrenergic receptor agonist brimonidine tartrate 0.5% reduces persistent facial erythema. Intradermal botulinum toxin injection is almost safe and ef …
Nonselective beta-blockers and alpha(2)-adrenergic agonists decrease erythema and flushing. The topical alpha-adrenergic receptor ago …
Pulsed dye laser followed by intradermal botulinum toxin type-A in the treatment of rosacea-associated erythema and flushing.
Al-Niaimi F, Glagoleva E, Araviiskaia E. Al-Niaimi F, et al. Dermatol Ther. 2020 Nov;33(6):e13976. doi: 10.1111/dth.13976. Epub 2020 Jul 27. Dermatol Ther. 2020. PMID: 32633449
Rosacea is a common inflammatory skin disease characterized by erythema, episodes of flushing, and inflammatory lesions. ...In this article, we present our experience on the successful combination of both pulsed dye laser and intradermal botulin …
Rosacea is a common inflammatory skin disease characterized by erythema, episodes of flushing, and inflammatory lesions. ...In …
Pulsed dye laser treatment of rosacea using a novel 15 mm diameter treatment beam.
Bernstein EF, Schomacker K, Paranjape A, Jones CJ. Bernstein EF, et al. Lasers Surg Med. 2018 Oct;50(8):808-812. doi: 10.1002/lsm.22819. Epub 2018 Apr 10. Lasers Surg Med. 2018. PMID: 29635699 Free PMC article. Clinical Trial.
BACKGROUND: The pulsed-dye laser has been used to treat facial redness and rosacea for decades. Recent advances in dye laser technology enable 50% higher output energies supporting 50% larger treatment areas, and beam-diameters up …
BACKGROUND: The pulsed-dye laser has been used to treat facial redness and rosacea for decades. Recent ad …
Treatment of Erythematotelangiectatic Rosacea With Pulsed-Dye Laser and Oxymetazoline 1.0% Cream: A Retrospective Study.
Suggs AK, Macri A, Richmond H, Munavalli G, Friedman PM. Suggs AK, et al. Lasers Surg Med. 2020 Jan;52(1):38-43. doi: 10.1002/lsm.23176. Epub 2019 Nov 10. Lasers Surg Med. 2020. PMID: 31709571
BACKGROUND AND OBJECTIVES: Pulsed-dye laser (PDL) and oxymetazoline 1.0% cream are each used for the treatment of erythematotelangiectatic (ET) rosacea. PDL targets oxyhemoglobin and can reduce facial erythema and telangiectasias. Oxymeta …
BACKGROUND AND OBJECTIVES: Pulsed-dye laser (PDL) and oxymetazoline 1.0% cream are each used for the treatment of eryth …
Comparative effectiveness of nonpurpuragenic 595-nm pulsed dye laser and microsecond 1064-nm neodymium:yttrium-aluminum-garnet laser for treatment of diffuse facial erythema: A double-blind randomized controlled trial.
Alam M, Voravutinon N, Warycha M, Whiting D, Nodzenski M, Yoo S, West DP, Veledar E, Poon E. Alam M, et al. J Am Acad Dermatol. 2013 Sep;69(3):438-43. doi: 10.1016/j.jaad.2013.04.015. Epub 2013 May 17. J Am Acad Dermatol. 2013. PMID: 23688651 Clinical Trial.
BACKGROUND: Facial erythema is a common symptom that responds to vascular laser treatment, but there are few comparative studies. OBJECTIVE: We sought to compare the effectiveness of microsecond 1064-nm neodymium:yttrium-aluminum-garnet (Nd:YAG) laser …
BACKGROUND: Facial erythema is a common symptom that responds to vascular laser treatment, but there are few comparativ …
Enhancing effect of pretreatment with topical niacin in the treatment of rosacea-associated erythema by 585-nm pulsed dye laser in Koreans: a randomized, prospective, split-face trial.
Kim TG, Roh HJ, Cho SB, Lee JH, Lee SJ, Oh SH. Kim TG, et al. Br J Dermatol. 2011 Mar;164(3):573-9. doi: 10.1111/j.1365-2133.2010.10174.x. Epub 2011 Feb 17. Br J Dermatol. 2011. PMID: 21143465 Clinical Trial.
BACKGROUND: Rosacea is a chronic dermatosis that is usually confined to the face. A pulsed dye laser (PDL) system has been proven to be effective in treating rosacea-associated erythema and telangiectasias. ...There were no remarka …
BACKGROUND: Rosacea is a chronic dermatosis that is usually confined to the face. A pulsed dye laser (PDL …
Comparison of the efficacy and safety of pulsed dye laser, narrow-band intense pulsed light, and broad-band intense pulsed light in the treatment of erythematotelangiectatic rosacea.
Tang J, He X. Tang J, et al. Am J Transl Res. 2025 Jul 15;17(7):5530-5543. doi: 10.62347/LMUT4952. eCollection 2025. Am J Transl Res. 2025. PMID: 40821078 Free PMC article.
BACKGROUND: Erythematotelangiectatic rosacea (ETR) is a chronic dermatological condition characterized by persistent facial erythema and visible telangiectasia. This study aims to compare the efficacy, safety, and patient satisfaction associated with pulse …
BACKGROUND: Erythematotelangiectatic rosacea (ETR) is a chronic dermatological condition characterized by persistent facial …
Interventions for rosacea.
van Zuuren EJ, Fedorowicz Z, Carter B, van der Linden MM, Charland L. van Zuuren EJ, et al. Cochrane Database Syst Rev. 2015 Apr 28;2015(4):CD003262. doi: 10.1002/14651858.CD003262.pub5. Cochrane Database Syst Rev. 2015. PMID: 25919144 Free PMC article.
Low dose minocycline (45 mg) was effective for papulopustular rosacea (low quality evidence).Oral tetracycline was compared with topical metronidazole in four studies and showed no statistically significant difference between the two treatments for any outcome (low to mode …
Low dose minocycline (45 mg) was effective for papulopustular rosacea (low quality evidence).Oral tetracycline was compared with topi …
44 results